Milestones

  1. 2007:
    • SunWay Biotech Co., LTD. was established and its facility was qualified for GMP certification.
  2. 2008:
    • The research and technology of Monascus purpureus  NTU 568 (red yeast) and Lactobacillus paracasei  subsp. paracasei  NTU 101 (probiotics) were exclusively authorized by National Taiwan University.
    • Red yeast (Monascus purpureus) beverages were awarded the Certification of Symbol of National Quality (SNQ).
  3. 2009:
    • Developing red yeast products in capsule.
  4. 2010:
    • Probiotic products were awarded the Certification of Symbol of National Quality (SNQ).
    • Red yeast capsulate products were granted the Certification of Halal and the US federal trademark “HCW”.
  5. 2011:
    • The fermented manufacturing processes of red yeast-related products were granted patents and certificates from multiple nations.
  6. 2012:
    • The main facility was expanded and certified with ISO 22000 and HACCP.
    • Application and development of non-active Lactobacillus, collagen powder, and herbal tablets.
  7. 2013:
    • A red yeast product (ANKASCIN 568) was granted the Health Food Permit (No. A00231).
  8. 2014:
    • Development of Lactobacillus soft sweets.
  9. 2015
    • The red yeast extract (ANKASCIN 568-R) was accepted by the US FDA as an NDI (New Dietary Ingredient)
    • Two clinical trials were completed in Taiwan, demonstrating ANKASCIN 568 Plus+ was effective in lowering blood glucose and blood lipids (total cholesterol and low-density lipoprotein cholesterol)
    • Red yeast and Lactobacillus ingredient supply and contract manufacturing of private label finished products.
  10. 2016
    • Acquired health claim certificate for new red yeast capsules in Taiwan
    • Clinical results on red yeast ingredient’s blood sugar effects were accepted by a peer-reviewed journal
    • Accomplished clinical trial on the probiotic Vigiis 101-LAB ingredient (gut microbiota effects)
    • 圖片1
  11. 2017
    • Acquired 2nd health claim certificate for new red yeast capsules in Taiwan
    • A food supplement containing ANKASCIN® 568-R was approved by Italian authorities
    • Clinical results on red yeast ingredient’s blood pressure effects were accepted by a peer-reviewed journal
    • SunWay’s management system has been certified by TÜV Rheinland
    • Established Songshan Lake SunWay Biotechnology in Dongguan, Guangdong
      Initial public offering
    • 圖片4圖片5圖片6
  12. 2018
    • Owing to our new safety data, US FDA approved new NDI (#1071) for ANKASCIN 568-R
    • Accomplished clinical trials on the probiotic Vigiis 101-LAB ingredient’s (gut transition effects)
    • 圖片7  圖片8  圖片9
  13. 2019
    • Obtained D & B’s business operation capability certification
    • Cooperate with NTU Hospital to conduct clinical trials related to probiotics and H. pylori
    • NTU 101 is honored to be as cover of Food & Function Journal
    • Red yeast rice ANKASCIN 568-R was invited to write a review
    • New red yeast rice raw material 568-P developed
    • 圖片11  圖片12  圖片13
  14. 2020
    • Taiwanese product red yeast rice won the Taiwan Health Food Society Nutrition and Health Food Innovation Award
  15. 2021
    • SunWay is listed on Taiwan Emerging Stock Market
    • Cooperation with US Florida brand owner